Indian Journal of Ophthalmology, Vol 61, Iss 8, Pp 433-434 (2013)
Druh dokumentu:
article
ISSN:
0301-4738 1998-3689
DOI:
10.4103/0301-4738.116072
Popis:
Corneal collagen cross-linking with riboflavin and UVA light (CXL) is the only method designed to arrest the progression of keratoconus. Visual improvement generally starts 3 months after treatment. Reduction is coma seen on aberrometry in early postoperative phase is also responsible for the improvement in visual acuity. In the light of currently available data we can thus say that CXL is a safe procedure that is successful in arresting keratoconus.